Is a complete GMED research report available?

No complete published report is available for Globus Medical, Inc. (GMED) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Globus Medical, Inc. (GMED)

NYSE: GMED · USD

$81.1

+0.20 (+0.3%)· Recorded snapshot

Market cap	10.9B
Revenue (ttm)	3.1B
Net income (ttm)	535.4M
EPS (ttm)	$3.91
Shares out	134.3M
P/E (trailing)	20.7x
P/E (forward)	15.9x
Volume	636,708
Beta	0.96

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001237831
Company name	Globus Medical, Inc.
Country	United States
Country code	US
CUSIP number	379577208
Earnings date	2026-11-05
Earnings time	amc
Employees	6,000
Employees change	700
Employees growth	13.21%
Enterprise value	$10.2B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2003
Industry	Medical Devices
IPO date	2012-08-03
Is primary listing	Yes
Is SPAC	No
ISIN number	US3795772082
Last 10-K release date	2026-02-24
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$10.9B
Market cap category	Large-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$81.10
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	GMED
U.S. state	Pennsylvania
Website	https://www.globusmedical.com

Metric

Value

Amount currency

USD

CIK code

0001237831

Company name

Globus Medical, Inc.

Country

United States

Country code

CUSIP number

379577208

Earnings date

2026-11-05

Earnings time

amc

Employees

6,000

Employees change

700

Employees growth

13.21%

Enterprise value

$10.2B

Exchange

NYSE

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2003

Industry

Medical Devices

IPO date

2012-08-03

Is primary listing

Yes

Is SPAC

ISIN number

US3795772082

Last 10-K release date

2026-02-24

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$10.9B

Market cap category

Large-Cap

Next earnings date

2026-11-05

Options

Yes

Price

$81.10

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

GMED

U.S. state

Pennsylvania

Website

https://www.globusmedical.com

Metric	Value
Adjusted P/E ratio	16.48x
Average P/E ratio (10Y)	46.32x
Average P/E ratio (3Y)	67.66x
Average P/E ratio (5Y)	56.33x
Earnings yield	4.82%
EV/Earnings	19.07x
EV/EBIT	13.98x
EV/EBITDA	10.11x
EV/FCF	13.52x
EV/Sales	3.25x
FCF / EV yield	7.4%
FCF yield	6.91%
Forward EV/Sales	3.11x
Forward P/E	15.9x
Forward P/S	3.33x
Graham number	55.89894
Graham upside	-31.4%
Industry forward P/E	19.74x
Industry P/E	39.16x
Lynch fair value	$93.09
Lynch upside	14.24%
P/(FCF - SBC) ratio	15.48x
P/(OCF - SBC) ratio	12.7x
P/B ratio	2.28x
P/E ratio	20.74x
P/FCF ratio	14.48x
P/OCF ratio	12.02x
P/S ratio	3.48x
PEG ratio	1.21x
Price / tangible book value	4.15x
Price/EBITDA ratio	10.83x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

16.48x

Average P/E ratio (10Y)

46.32x

Average P/E ratio (3Y)

67.66x

Average P/E ratio (5Y)

56.33x

Earnings yield

4.82%

EV/Earnings

19.07x

EV/EBIT

13.98x

EV/EBITDA

10.11x

EV/FCF

13.52x

EV/Sales

3.25x

FCF / EV yield

7.4%

FCF yield

6.91%

Forward EV/Sales

3.11x

Forward P/E

15.9x

Forward P/S

3.33x

Graham number

55.89894

Graham upside

-31.4%

Industry forward P/E

19.74x

Industry P/E

39.16x

Lynch fair value

$93.09

Lynch upside

14.24%

P/(FCF - SBC) ratio

15.48x

P/(OCF - SBC) ratio

12.7x

P/B ratio

2.28x

P/E ratio

20.74x

P/FCF ratio

14.48x

P/OCF ratio

12.02x

P/S ratio

3.48x

PEG ratio

1.21x

Price / tangible book value

4.15x

Price/EBITDA ratio

10.83x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	23.22%
EBITDA margin	32.12%
Effective tax rate	18.89%
FCF margin	24.03%
Gross margin	68.98%
Operating margin	23.22%
Pretax margin	20.99%
Profit margin	17.03%
Profit per employee	$89,239
Profitable quarters	9
Profitable years	17
Revenue per employee	$524,156
ROA	8.74%
ROA (5Y)	6.25%
ROCE	14.58%
ROE	11.81%
ROE (5Y)	7.76%
ROIC	13.93%
ROIC (5Y)	11.56%
SBC / revenue	1.56%
Tax / revenue	3.96%

Metric

Value

EBIT margin

23.22%

EBITDA margin

32.12%

Effective tax rate

18.89%

FCF margin

24.03%

Gross margin

68.98%

Operating margin

23.22%

Pretax margin

20.99%

Profit margin

17.03%

Profit per employee

$89,239

Profitable quarters

Profitable years

Revenue per employee

$524,156

ROA

8.74%

ROA (5Y)

6.25%

ROCE

14.58%

ROE

11.81%

ROE (5Y)

7.76%

ROIC

13.93%

ROIC (5Y)

11.56%

SBC / revenue

1.56%

Tax / revenue

3.96%

Metric	Value
EPS growth	51.94%
EPS growth (Q)	-26.17%
EPS growth (QoQ)	22.22%
EPS growth 10Y	12.26%
EPS growth 3Y	25.03%
EPS growth 5Y	16.79%
EPS growth years	1
FCF growth	43.26%
FCF growth (Q)	464.08%
FCF growth (QoQ)	8.49%
FCF growth 3Y	84.12%
FCF growth 5Y	30.1%
Gross profit growth	23.08%
Gross profit growth (Q)	9.08%
Gross profit growth 3Y	38.67%
Gross profit growth 5Y	25.71%
Net income growth	50.13%
Net income growth (Q)	-25.28%
Net income growth (QoQ)	21.94%
Net income growth 3Y	37.86%
Net income growth 5Y	23.81%
Net income growth years	1
OCF growth	36.05%
OCF growth (Q)	169.37%
OCF growth (QoQ)	3.65%
OCF growth 10Y	19.53%
OCF growth 3Y	70.02%
OCF growth 5Y	28.86%
Operating income growth	57.45%
Operating income growth (Q)	51.36%
Operating income growth 3Y	43.37%
Operating income growth 5Y	26.41%
Revenue growth	19.74%
Revenue growth (Q)	5.94%
Revenue growth (QoQ)	3.92%
Revenue growth 10Y	18.96%
Revenue growth 3Y	42.06%
Revenue growth 5Y	27.65%
Revenue growth quarters	5
Revenue growth years	16

Metric

Value

EPS growth

51.94%

EPS growth (Q)

-26.17%

EPS growth (QoQ)

22.22%

EPS growth 10Y

12.26%

EPS growth 3Y

25.03%

EPS growth 5Y

16.79%

EPS growth years

FCF growth

43.26%

FCF growth (Q)

464.08%

FCF growth (QoQ)

8.49%

FCF growth 3Y

84.12%

FCF growth 5Y

30.1%

Gross profit growth

23.08%

Gross profit growth (Q)

9.08%

Gross profit growth 3Y

38.67%

Gross profit growth 5Y

25.71%

Net income growth

50.13%

Net income growth (Q)

-25.28%

Net income growth (QoQ)

21.94%

Net income growth 3Y

37.86%

Net income growth 5Y

23.81%

Net income growth years

OCF growth

36.05%

OCF growth (Q)

169.37%

OCF growth (QoQ)

3.65%

OCF growth 10Y

19.53%

OCF growth 3Y

70.02%

OCF growth 5Y

28.86%

Operating income growth

57.45%

Operating income growth (Q)

51.36%

Operating income growth 3Y

43.37%

Operating income growth 5Y

26.41%

Revenue growth

19.74%

Revenue growth (Q)

5.94%

Revenue growth (QoQ)

3.92%

Revenue growth 10Y

18.96%

Revenue growth 3Y

42.06%

Revenue growth 5Y

27.65%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-154.8M
Depreciation and amortization	$280M
EBIT	$730.3M
EBITDA	$1B
EPS	$3.91
FCF per share	$5.63
Financing cash flow	$-135.1M
Free cash flow	$755.6M
Free cash flow minus SBC	$706.6M
Gross profit	$2.2B
Income taxes	$124.7M
Investing cash flow	$-499M
Net cash flow	$278.3M
Net income	$535.4M
Operating cash flow minus SBC	$861.4M
Operating income	$730.3M
Revenue	$3.1B
Stock-based compensation	$49M

Metric

Value

Capital expenditures

$-154.8M

Depreciation and amortization

$280M

EBIT

$730.3M

EBITDA

$1B

EPS

$3.91

FCF per share

$5.63

Financing cash flow

$-135.1M

Free cash flow

$755.6M

Free cash flow minus SBC

$706.6M

Gross profit

$2.2B

Income taxes

$124.7M

Investing cash flow

$-499M

Net cash flow

$278.3M

Net income

$535.4M

Operating cash flow minus SBC

$861.4M

Operating income

$730.3M

Revenue

$3.1B

Stock-based compensation

$49M

Metric	Value
Altman Z-Score	10.42
Book value per share	$35.52
Debt / EBITDA	0.11
Debt / equity	0.02
Debt / FCF	0.15
Goodwill	$1.4B
Long-term assets	$3.3B
Long-term liabilities	$240.3M
Net cash (debt)	$728.6M
Net cash / market cap	6.66%
Net cash growth	574.39%
Net debt / EBITDA	-0.72
Net debt / equity	-0.15
Net debt / FCF	-0.96
Piotroski F-Score	7
Property, plant and equipment	$593.4M
Shareholders' equity	$4.8B
Tangible book value	$2.6B
Tangible book value per share	$19.65
Total assets	$5.5B
Total cash	$595.1M
Total debt	$111.9M
Total liabilities	$719.7M
WACC	9.43%

Metric

Value

Altman Z-Score

10.42

Book value per share

$35.52

Debt / EBITDA

0.11

Debt / equity

0.02

Debt / FCF

0.15

Goodwill

$1.4B

Long-term assets

$3.3B

Long-term liabilities

$240.3M

Net cash (debt)

$728.6M

Net cash / market cap

6.66%

Net cash growth

574.39%

Net debt / EBITDA

-0.72

Net debt / equity

-0.15

Net debt / FCF

-0.96

Piotroski F-Score

Property, plant and equipment

$593.4M

Shareholders' equity

$4.8B

Tangible book value

$2.6B

Tangible book value per share

$19.65

Total assets

$5.5B

Total cash

$595.1M

Total debt

$111.9M

Total liabilities

$719.7M

WACC

9.43%

Metric	Value
Asset turnover	0.6
Current assets	$2.2B
Current liabilities	$479.3M
Current ratio	4.62
Inventory turnover	1.23
Net working capital	$1.2B
Quick ratio	2.78
Working capital	$1.7B
Working capital turnover	2.07

Metric

Value

Asset turnover

0.6

Current assets

$2.2B

Current liabilities

$479.3M

Current ratio

4.62

Inventory turnover

1.23

Net working capital

$1.2B

Quick ratio

2.78

Working capital

$1.7B

Working capital turnover

2.07

Metric	Value
Buyback yield / dilution	1.18%
Dividend yield	0%
Shareholder yield	1.18%

Metric

Value

Buyback yield / dilution

1.18%

Dividend yield

Shareholder yield

1.18%

Metric	Value
10Y price change	270.05%
10Y return CAGR	13.98%
10Y total return	270.05%
150-day SMA	$81.52
1D price change	0.25%
1M price change	8.75%
1M total return	8.75%
1W price change	2.63%
1W total return	2.63%
1Y price change	28.11%
1Y return CAGR	28.13%
1Y total return	28.11%
20-day SMA	$77.47
200-day SMA	$83.60
3M price change	3.57%
3M total return	3.57%
3Y price change	77.49%
3Y return CAGR	21.07%
3Y total return	77.49%
50-day SMA	$77.87
50-day SMA vs 200-day SMA	50under200
52-week high	$101.40
52-week high date	2026-01-08
52-week low	$59.51
52-week low date	2025-11-03
5Y price change	5.14%
5Y return CAGR	1.01%
5Y total return	5.14%
6M price change	-13.51%
6M total return	-13.51%
All-time high	$101.40
All-time high date	2026-01-08
All-time low	$10.26
All-time low date	2012-12-31
Average true range (ATR)	$2.05
Average volume	1.3M
Beta (1Y)	-0.04
Beta (2Y)	0.71
Beta (5Y)	0.96
Change from 52-week high	-20.02%
Change from 52-week low	36.28%
Change from all-time high	-20.08%
Change from all-time low	689.86%
Change from open	-0.48%
Day's gap	0.73%
Dollar volume	$51.6M
High price	$81.63
Low price	$80.93
Monthly RSI	53.4
Open price	$81.49
Position in 52-week range	24.29%
Premarket change	0.12%
Premarket close	$80.90
Premarket price	$81.00
Premarket volume	1.3K
Previous close	$80.90
Price vs 150-day SMA	-0.59%
Price vs 20-day SMA	4.61%
Price vs 200-day SMA	-3.07%
Price vs 50-day SMA	4.07%
Relative volume	0.48
RSI	60.67
Sharpe ratio	0.65
Sharpe ratio (3Y)	0.49
Sharpe ratio (5Y)	0.11
Sortino ratio	1.54
Sortino ratio (3Y)	0.96
Sortino ratio (5Y)	0.31
Volume	636.7K
Weekly RSI	51.45
YTD price change	-7.18%
YTD total return	-7.18%

Metric

Value

10Y price change

270.05%

10Y return CAGR

13.98%

10Y total return

270.05%

150-day SMA

$81.52

1D price change

0.25%

1M price change

8.75%

1M total return

8.75%

1W price change

2.63%

1W total return

2.63%

1Y price change

28.11%

1Y return CAGR

28.13%

1Y total return

28.11%

20-day SMA

$77.47

200-day SMA

$83.60

3M price change

3.57%

3M total return

3.57%

3Y price change

77.49%

3Y return CAGR

21.07%

3Y total return

77.49%

50-day SMA

$77.87

50-day SMA vs 200-day SMA

50under200

52-week high

$101.40

52-week high date

2026-01-08

52-week low

$59.51

52-week low date

2025-11-03

5Y price change

5.14%

5Y return CAGR

1.01%

5Y total return

5.14%

6M price change

-13.51%

6M total return

-13.51%

All-time high

$101.40

All-time high date

2026-01-08

All-time low

$10.26

All-time low date

2012-12-31

Average true range (ATR)

$2.05

Average volume

1.3M

Beta (1Y)

-0.04

Beta (2Y)

0.71

Beta (5Y)

0.96

Change from 52-week high

-20.02%

Change from 52-week low

36.28%

Change from all-time high

-20.08%

Change from all-time low

689.86%

Change from open

-0.48%

Day's gap

0.73%

Dollar volume

$51.6M

High price

$81.63

Low price

$80.93

Monthly RSI

53.4

Open price

$81.49

Position in 52-week range

24.29%

Premarket change

0.12%

Premarket close

$80.90

Premarket price

$81.00

Premarket volume

1.3K

Previous close

$80.90

Price vs 150-day SMA

-0.59%

Price vs 20-day SMA

4.61%

Price vs 200-day SMA

-3.07%

Price vs 50-day SMA

4.07%

Relative volume

0.48

RSI

60.67

Sharpe ratio

0.65

Sharpe ratio (3Y)

0.49

Sharpe ratio (5Y)

0.11

Sortino ratio

1.54

Sortino ratio (3Y)

0.96

Sortino ratio (5Y)

0.31

Volume

636.7K

Weekly RSI

51.45

YTD price change

-7.18%

YTD total return

-7.18%

Metric	Value
Float	110.9M
Float percentage	82.61%
Shares change (QoQ)	-0.58%
Shares change (YoY)	-1.18%
Shares held by insiders	17.18%
Shares held by institutions	90.09%
Shares outstanding	134.3M
Short % of float	7.61%
Short % of shares	6.28%
Short ratio	5.5 days

Metric

Value

Float

110.9M

Float percentage

82.61%

Shares change (QoQ)

-0.58%

Shares change (YoY)

-1.18%

Shares held by insiders

17.18%

Shares held by institutions

90.09%

Shares outstanding

134.3M

Short % of float

7.61%

Short % of shares

6.28%

Short ratio

5.5 days

Globus Medical, Inc. (GMED)

Price

Financial snapshot

Fair-value bridge

Latest news · GMED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GMED indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on GMED

Frequently asked questions